Objective: Studies provide conflicting results about the impact of comorbid conditions on the quality of chronic illness care. We assessed the effect of comorbidity type (concordant, discordant, or both) on the receipt of guideline-recommended care among patients with diabetes.
A lthough treatment of chronically ill patients consumes more than three-fourths of US healthcare expenditures, evidence suggests that these patients receive just over half of the appropriate recommended care. 1, 2 This has implications particularly for patients with diabetes, as approximately 40% suffer from 3 or more comorbidities. 1 Studies assessing the impact of comorbidities on the quality of chronic illness care provide mixed results. One study found that discussion of unrelated conditions during a clinical encounter decreased the likelihood of addressing elevated blood pressure in patients with diabetes. 3 Similarly, patients with uncontrolled hypertension were less likely to receive antihypertensive therapy intensification if they had greater numbers of unrelated conditions. 4 Conversely, emerging evidence suggests that the presence of multiple comorbidities may actually enhance quality for chronically ill patients. We recently reported that hypertensive patients with greater complexity were more likely to receive high quality care than those with fewer comorbidities. 5 This and other studies 6, 7 highlight the need for additional research to elucidate the impact of comorbid conditions on the quality of chronic illness care.
Using a framework employed in earlier research, 5, 8 we identified comorbidities that were concordant and discordant with diabetes. Diabetes-concordant comorbidities have similar pathogenesis and treatment strategies, whereas diabetes-discordant comorbidities are not related to diabetes development or management. We examined the impact of comorbidity type (concordant, discordant, or both) on 3 diabetes quality-of-care measures: glycemic, blood pressure, and lipid control. We also assessed the relationship between comorbidity type and likelihood of receiving overall good quality for all 3 measures.
METHODS

Study Population
We identified Veterans with diabetes receiving primary care at 7 Veterans Affairs (VA) facilities from July, 2007 to June, 2008. We classified patients as having diabetes if, in the study interval or 2 years prior, they had: 2 outpatient or 1 inpatient diagnosis code indicating diabetes 9 ; a filled prescription for diabetes medication; or at least 2 glucose readings Z200 mg/dL. We excluded patients with limited life expectancy (diagnosis of metastatic cancer or hospice/ palliative care use) and who died during the study or follow-up period.
Diabetes-concordant and Diabetes-discordant Conditions
Using diagnosis and procedure codes in the VA National Patient Care Database 10 and Fee Basis files, 11 we identified patients with diabetes-concordant (hypertension, ischemic heart disease, and hyperlipidemia) and diabetesdiscordant (arthritis, chronic obstructive pulmonary disease, and depression) conditions within 2 years before their most recent primary care encounter during the study interval. We categorized patients into mutually exclusive diabetes condition groups: (1) no comorbid conditions; (2) discordant-only conditions; (3) concordant-only conditions; (4) both concordant and discordant conditions. 5
Study Outcomes
We used American Diabetes Association recommendations 12 to assess hemoglobin A1c (HbA1c) (<7%), blood pressure (<130/80 mm Hg), and low-density lipoprotein cholesterol (LDL-C) (<100 mg/dL) control at index. Among uncontrolled patients, we examined a 6-month follow-up period to determine whether appropriate medication adjustments were made or the patient's most recent follow-up reading was at goal ( Fig. 1 ).
We obtained HbA1c, blood pressure, and LDL-C values from the VA Network data warehouse, which includes data from each hospital's electronic medical records. We assessed control at index using the patient's most recent readings. We used VA Decision Support System pharmacy data to identify current medications (prescriptions filled within 100 d before index) 13 and those received during follow-up. We used the data warehouse to identify prescriptions filled outside the VA. We computed average daily medication dosages using the formula: (quantity of medication/days supplied) Â numeric dosage. We calculated overall good quality for each measure by adding the number of patients controlled at index and those receiving appropriate follow-up care.
Patient with diabetes
Did the patient's index reading meet the ADA guideline?
•HbA1C < 7%
•BP < 130/80 mm Hg 
Statistical Analyses
We assessed the proportion of patients that were controlled at index; received appropriate follow-up care; and received overall good quality by chronic condition group for the 3 measures. We used logistic regression to determine the impact of coexisting conditions on the likelihood of being controlled at index; receiving appropriate follow-up care; and receiving overall good quality. In addition, we compared the likelihood of receiving overall good quality for 1 or more of the measures, using generalized ordered logistic regression. Models were adjusted for age, illness burden defined by Diagnostic Cost Group Relative Risk Scores, 14 and accounted for clustering of patients by facility (Table 1) . Analyses were conducted using SAS version 9.2 (SAS Institute Inc., Cary, NC) and Stata 10 (StataCorp LP, College Station, TX).
Sensitivity Analyses
We assessed the impact of a shorter follow-up interval (3 mo); exclusion of patients with limited life expectancy; use of VA quality indicators [HbA1c (r9%) and blood pressure (<140/90 mm Hg)]; and effect of VA primary and specialty care utilization on the study outcomes. We identified 25 relevant specialty care clinics for the study conditions, and designated an encounter as specialty care if the patient had a condition and a visit to the relevant clinic (eg, patient with chronic obstructive pulmonary disease and a visit to pulmonary clinic) during the prior year. In addition, because diabetes and depression commonly co-occur, we conducted univariate analyses to evaluate the influence of depression on study outcomes.
The Institutional Review Board at Baylor College of Medicine and the Michael E. DeBakey VA Research and Development Committee approved this study. The funding sources played no role in the study conduct or interpretation.
RESULTS
We identified 35,872 patients with diabetes meeting inclusion criteria. Of these, 5.8% had no comorbidities, 58.0% had concordant only, 2.0% had discordant only, and 34.2% had both ( Table 2) . We excluded 2337 patients who had limited life expectancy or died during follow-up.
For all measures, the proportion of patients controlled at index was lowest among those with no comorbidities (Table 3 ). The group with both concordant and discordant comorbidities had the highest proportion receiving appropriate follow-up care for glycemic (61.2%), blood pressure (66.5%), and LDL-C (55.8%) control. The no comorbidities group had the lowest proportion receiving appropriate follow-up care for glycemic and LDL-C control (50.0% and 25.8%, respectively), whereas the discordant-only group had the lowest proportion receiving appropriate follow-up for blood pressure control (44.0%). The total proportion of patients receiving overall good quality was 77.8% for glycemic, 80.4% for blood pressure, and 85.5% for LDL-C control. Similar to findings for control at index, patients with both types of conditions had the highest proportion of patients receiving overall good quality for each measure, whereas the no comorbidities group had the lowest.
Adjusting for age and illness burden, patients with both types of comorbidites were more likely than patients with no comorbidities to achieve glycemic and LDL-C control at index [odds ratio (OR), 2.15; 95% confidence interval (CI), 1.88-2.43; and OR, 2.22; 95% CI, 1.94-2.49, respectively )], (Table 3) . Patients with concordant-only comorbidities and those with both types were more likely than those with no comorbidities to receive appropriate follow-up care and overall good quality for each measure. Patients with discordant-only comorbidities were more likely than those with no comorbidities to receive overall good quality for glycemic (OR, 1.48; 95% CI, 1.13-1.83) and LDL-C (OR, 1.30; 95% CI, 1.06-1.59) control. When assessing attainment of guideline-recommended levels across the 3 quality-of-care measures simultaneously, patients with concordant only and both types of comorbidities were more likely than those with no comorbidities to receive overall good quality (OR, 2.00; 95% CI, 1.82-2.20 and OR, 2.17; 95% CI, 1.96-2.39, respectively) ( Table 4 ).
We found similar results for overall good quality using a 3-month follow-up period and when assessing less stringent glycemic (HbA1c r9%) and blood pressure (<140/90 mm Hg) thresholds. Our findings that the most complex patients received higher levels of overall good quality for each measure persisted after adjusting for primary and specialty care visits. Although a higher proportion of patients excluded for limited life expectancy or death were in the both condition group, study outcomes were similar when including these patients in our analyses. Finally, univariate analyses showed that depression was not associated with decreased levels of overall good quality for any of the measures (data not shown).
DISCUSSION
We assessed quality for 3 dimensions of diabetes care: glycemic, blood pressure, and LDL-C control, and determined how this varied by condition group. We found that patients with both concordant and discordant conditions and those with concordant only were more likely than those with no comorbidities to receive overall good quality for each dimension examined. These findings did not change when we controlled for prior visits, assessed a shorter follow-up period, or evaluated care using VA performance indicators for glycemic and blood pressure control. Patients with both types of comorbidities were also more likely than those with no comorbidities to receive overall good quality for all 3 dimensions of diabetes care combined.
This work extends earlier studies by examining the correlation between different types of conditions and quality for 3 dimensions of diabetes care. 15, 16 As assessed by current standards, provision of high quality, comprehensive care in this population necessitates adherence to numerous clinical practice guidelines. Although our results show high levels of guideline-recommended care among the most complex diabetic patients, studies indicate that such care may not be equally beneficial across all chronically ill patients. 17, 18 For example, elderly patients with multiple comorbidities receiving care in accordance with multiple guidelines may have worse outcomes. This highlights the intricacies of managing such patients and the need to adapt current methods of quality assessment and provider reimbursement to address the challenges unique to this patient population.
Several factors may contribute to the higher quality found among more complex diabetic patients. First, providers may be more likely to treat coexisting conditions in complex patients to reduce the risk of adverse consequences. For example, they may aggressively target blood pressure and lipid control because their benefit in preventing or slowing the progression of coronary artery disease has been well documented. 12 In addition, these findings may result in part from system-level processes aimed at increasing evidence-based care within the VA. 19 Medication adherence and healthcare utilization may also influence the relationship between diabetes complexity and quality of care. Patients with both types of comorbidities had more frequent primary and specialty care visits than other patients. This increased healthcare exposure may lead to stronger provider/patient relationships, which may increase adherence to treatment plans, including recommended visits and prescribed medications. 20, 21 More complex patients may also use ancillary services, such as case management, more often which may improve their overall health and increase adherence. 20 However, we found that controlling patient visits did not impact our findings. Depression and diabetes frequently co-occur, yet differ in pathogenesis and treatment; therefore, we felt this was an ideal discordant condition. 8 Although some studies have shown that depression is associated with poorer quality of diabetes care, 22, 23 others report that patients with comorbid mental illness, including depression, received similar quality of diabetes care to those without mental disorders. 24, 25 We examined the influence of depression on our models and did not find a significant impact.
Our study's strengths include a large study population, evaluation of multiple dimensions of diabetes care, inclusion of a follow-up period, and use of a novel multinomial logistic approach to assess the impact of comorbidities on comprehensive diabetes care. We ascertained data from VA administrative sources, which provide extensive inpatient and outpatient VA utilization data 10 and obtained clinical variables from the data warehouse which includes data directly from VA electronic medical records. Nonetheless, there are limitations that should be considered when interpreting our findings. First, we conducted this study in the VA, which serves a predominantly male, elderly patient population; thus generalizability may be limited. In addition, we identified common chronic conditions to classify patients into condition groups, but the conditions chosen may not reflect all existing comorbidities. Finally, although the patient distribution across the 4 condition groups is not balanced, each group is large enough for appropriate statistical modeling. We found that patients with diabetes with the highest level of complexity did not have lower levels of overall good quality compared with less complex patients. Further, complex patients were more likely to receive overall good quality of care across all 3 dimensions of care. This suggests that increased complexity does not necessarily predispose patients with diabetes to receiving poorer quality of care.
